Company · Spain
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,800 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track COFARES in PolicySpeak: request access →
Work at COFARES? so we know who speaks for it.
COFARES filed 2 positions between 8 Nov 2023 and 12 Feb 2024, across 2 of the 665 legislative files tracked here, attaching a full position paper 2 times.
Positioning OF COFARES, S.L ANTE THE PROPOSALS FOR DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use and repealing Directive 2001/83/EC and Directive 2009/35/EC For the attention of the person concerned: Cofares, Sociedad Cooperativa Farmaceutica Española D.S.
Filed in Spanish · English published by the European Commission
In relation to the European Commission’s decision to assess the period of early application of the Regulation on serious cross-border threats to health, in accordance with its Article 33, COFARES, Spanish Pharmaceutical Cooperative (hereinafter ‘Cofares’), welcomes this initiative and has prepared this document with the aim of providing input and comments.
Filed in Spanish · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put COFARES next to another organization. Same files, same register facts, side by side. Compare →
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Everything on this page comes from COFARES’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.